Myocardial protection in beating heart cardiac surgery: I: Pre- or postconditioning with inhibition of es-ENT1 nucleoside transporter and adenosine deaminase attenuates post-MI reperfusion-mediated ventricular fibrillation and regional contractile dysfunction

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 1, 2012, Pages

  Abd Elfattah, Anwar Saad ^a   Aly, Hamdy ^b   Hanan, Scott ^a   Wechsler, Andrew S ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE DERIVATIVE; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; ERYTHRO 9 (2 HYDROXY 3 NONYL) ADENINE; INOSINE; NITROBENZYLTHIOINOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEAMINATION; ENZYME INHIBITION; FEMALE; HEART CONTRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; OFF PUMP SURGERY; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 84862596156     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.10.095     Document Type: Article

References (28)

1. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76:1713-9.
2. Abd-Elfattah A, Higgins R, Latifi R, Merrell R. Targeting post-ischemic reperfusion injury: scientific dream and clinical reality. New Surg. 2001;1:41-51.
3. Abd-Elfattah AS, Jessen ME, Lekven J, Doherty NE III, Brunsting LA, Wechsler AS. Myocardial reperfusion injury: role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury. Circulation. 1988;78: III224-35.
4. Abd-Elfattah AS, Ding M, Wechsler AS. Intermittent aortic cross clamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning? J Thorac Cardiovasc Surg. 1995; 110:328-39.
5. Abd-Elfattah AS, Jessen ME, Wechsler AS. Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine: possible separation between ischemic and reperfusion injury. J Thorac Cardiovasc Surg. 1994;108:269-78.
6. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun JZ, Sekili S, Tang XL, Bolli R. Augmentation of endogenous adenosine attenuates myocardial "stunning" independently of coronary flow or hemodynamic effects. Circulation. 1993;88(5 Pt 1):2359-69.
7. Abd-Elfattah AS, Hoehner J, Wechsler AS. Identification of nucleoside transport binding sites in the human myocardium. Mol Cell Biochem. 1998;180:105-10.
8. Lu H, Chen C, Klaassen C. Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice. Drug Metab Dispos. 2004;32:1455-61.
9. Handa M, Choi DS, Caldeiro RM, Messing RO, Gordon AS, Diamond I. Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene. 2001;262: 301-7.
10. Rose JB, Naydenova Z, Bang A, Eguchi M, Sweeney G, Choi DS, et al. Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection. Am J Physiol Heart Circ Physiol. 2010;298:H771-7.
11. Ishikawa K, Ogawa I, Shimizu M, Koka H, Kamata N, Nakai S, et al. The importance of good endocardial reflow immediately after reperfusion for myocardial salvage in dogs. Jpn Circ J. 1991;55:983-93.
12. Mahgoub MA, Guo JH, Gao SP, Taher MM, Salter DD, Wechsler AS, et al. Hyperdynamic circulation of arteriovenous fistula preconditions the heart and limits infarct size. Ann Thorac Surg. 1999;68:22-8.
13. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
14. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-88.
15. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-6.
16. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res. 2005;67:124-33.
17. Walsh RS, Abd-Elfattah AS, Daly JJF, Wechsler AS, Downey J. Selective blockade of nucleoside transport channels prevents preconditioning of rabbit myocardium. Surg Forum. 1993;XLIV:234-6.
18. Walsh SR, Abd-Elfattah AS, Daly JJF, Wechsler AS, Downy J. Nucleoside transport prevents ischemic preconditioning (abstract). Circulation. 1993;88(Suppl): I-432.
19. Grube K, Rüdebusch J, Xu Z, Böckenholt T, Methner C, Müller T, et al. Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res Cardiol. 2011;106:385-96.
20. Abd-Elfattah AS, Ding M, Jessen ME, Wechsler AS. On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor. J Thorac Cardiovasc Surg. 2012;144: 243-9.
21. Xi J, McIntosh R, Shen X, Lee S, Chanoit G, Criswell H, et al. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol. 2009;47:684-90.
22. Urmaliya VB, Pouton CW, Ledent C, Short JL, White PJ. Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart. J Cardiovasc Pharmacol. 2010;56:379-88.
23. Mentzer RM Jr, Birjiniuk V, Khuri S, Lowe JE, Rahko PS, Weisel RD, et al. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg. 1999;229:643-9.
24. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW, AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005;45:1775-80.
25. Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985;71:994-1009.
26. Abd-Elfattah AS, Jessen ME, Lekven J, Doherty NE III, Brunsting LA, Wechsler AS. Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury. Circulation. 1988;78: III224-35.
27. Abd-Elfattah AS, Wechsler AS. Superiority of HPLC to assay for enzymes regulating adenine nucleotidase pool intermediates metabolism: 5′-nucleotidase, adenylate deaminase, adenosine deaminase and adenylosuccinate lyase: A simple and rapid determination of adenosine. J Liquid Chromatogr. 1987;10: 2653-94.
28. Mahgoub MA, Guo JH, Gao SP, Taher MM, Salter DD, Wechsler AS, Abd- Elfattah AS. Hyperdynamic circulation of arteriovenous fistula preconditions the heart and limits infarct size. Ann Thorac Surg. 1999;68:22-8.